Biogen (NASDAQ:BIIB) said that it has agreed to acquire Alcyone Therapeutics, a company based in Massachusetts. The deal involves an upfront payment of $85M, along with additional milestone payments tied to the development and regulatory approval of ThecaFlex DRx, which is associated with ...